NP47926 Biologic, Biosimilar’s and Methotrexate Injections

Description

Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland. Lot 8: Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 5: Infliximab Subcutaneous Injection Supply of infliximab subcutaneous injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents. Lot 9: Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 6: Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 7: Methotrexate (50mg/1ml concentration) Pre-Filled Syringe Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 1: Adalimumab Supply of adalimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 7 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 2: Etanercept Supply of etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 3: Golimumab Supply of golimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 4: Infliximab Intravenous Infusion Supply of infliximab intravenous infusion to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 6 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 10: Omalizumab Supply of omalizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 12: Tocilizumab Supply of tocilizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 13: Ustekinumab Supply of ustekinumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 9 Framework Participants. Full details of Goods and volumes can be found within the ITT documents. Lot 11: Tildrakizumab Supply of tildrakizumab to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.